top of page
Search


FDA Approves Zarxio, First Biosimilar Drug
The approval paves the way for alternatives to an entire class of complex and costly drugs to go on the market. Most brand-name drugs...
pharmanaming.com by Readge consultants
5 min read


FDA issues draft guidance on nonproprietary naming of biosimilars
The FDA announced the availability of a draft guidance describing its proposal on the nonproprietary naming of biological products....
pharmanaming.com by Readge consultants
2 min read
bottom of page